In treating a Type 2 diabetic patient with impaired pancreatic islet function, how might personalized endoderm stem cell-derived islet tissue be utilized?
A) To increase insulin production by transplanting the newly derived islet tissue into the patient’s pancreas
B) To directly stimulate the patient’s existing islet cells to enhance insulin sensitivity
C) To perform a genetic modification of the patient’s existing islet cells in vitro
D) To replace the patient’s damaged pancreas with a synthetic organ